Researchers at the Imaging Research Center are currently undertaking groundbreaking studies in the use of imaging for the early detection and treatment assessment of cancer. Early results validate the use of noninvasive imaging tools for the detection of and screening for cancer.
The TMII staff use full-body MRI service that measures body waves and blood flow to develop mathematical and statistical models to determine characteristics of a variety of cancers.
Specialists at TMII are studying how MRI signals effect oxygen in blood and tumor tissue. Our group images human subject in a newly opened research facility with the state-of-the-art free Tesla MRI system.
At TMII, we aim to develop and organize cancer-imaging trials in collaboration with many oncologists. New imaging methods are being developed that will allow clinicians not only to see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as on our understanding of how cancer arises. We intend to narrow or close the gap between science and patients.